PULL $PULL
A Small study by British scientists found that psilocybin may be at least as effective as antidepressants and could help people suffering from severe depression into remission.
Remission rates were twice as high in the psilocybin group than the antidepressant group
Comparing the effects of psilocybin directly to a more familiar, standard treatment clearly demonstrates the promise of this treatment to the public.
Dr Carhart- Harris explains these findings with the belief that the “psilocybin treatments are “getting more at the root causes of suffering” compared to the antidepressants.
full article
https://www.reuters.com/world/uk/magic-mushroom-compound-least-good-antidepressant-uk-study-2021-04-14/
Will be exciting to watch PULL grow in the rapidly emerging functional mushrooms and psychedelic sector as they start summer rollout.
CEO Ben Nikolaevsky was absolutely stoked PULL made their first US and Canadian sales off of Pure Mushroom products. He noted the functional mushroom wellness market is experiencing robust sales due to heightened immune system concern amidst the COVID-19 pandemic.
$PULL @ $0.245, mc $23.83 M